Spots Global Cancer Trial Database for dlt
Every month we try and update this database with for dlt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer | NCT01310478 | Colorectal Neop... | recombinant hum... | 17 Years - 70 Years | Fudan University | |
| Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) | NCT00986843 | Advanced Solid ... | HM30181AK table... | 19 Years - | Hanmi Pharmaceutical Company Limited | |
| Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer | NCT01310478 | Colorectal Neop... | recombinant hum... | 17 Years - 70 Years | Fudan University | |
| A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer | NCT01589419 | Locally Advance... | veliparib capecitabine radiation | 18 Years - 99 Years | AbbVie | |
| A Study of Oraxol® in Gastric Cancer Patients | NCT01491217 | Advanced Metast... Recurrent Gastr... | Paclitaxel | 19 Years - | Hanmi Pharmaceutical Company Limited | |
| Temsirolimus in Combination With Metformin in Patients With Advanced Cancers | NCT01529593 | Advanced Cancer... | Temsirolimus Metformin | 14 Years - | M.D. Anderson Cancer Center | |
| Sorafenib Plus S-1 in Advanced Solid Tumors | NCT01128998 | Advanced Solid ... | Sorafenib S-1 | 20 Years - 75 Years | National Health Research Institutes, Taiwan | |
| Dose-Escalation Study in Advanced Colon Cancer Patients | NCT00969046 | Colon Cancer | EPO906 (patupil... | 18 Years - | Novartis | |
| A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy. | NCT05983198 | Metastatic Cast... | 225Ac-PSMA-R2 68Ga-PSMA-R2 | 18 Years - | Novartis | |
| A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy. | NCT05983198 | Metastatic Cast... | 225Ac-PSMA-R2 68Ga-PSMA-R2 | 18 Years - | Novartis | |
| A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | NCT04177823 | Multiple Myelom... | Belantamab mafo... | 18 Years - | GlaxoSmithKline | |
| Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) | NCT00986843 | Advanced Solid ... | HM30181AK table... | 19 Years - | Hanmi Pharmaceutical Company Limited | |
| Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor | NCT02151357 | Cancer | DCBCI0901 | 20 Years - 80 Years | Standard Chem. & Pharm. Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
